(EN)
The present invention provides new substituted prolinamides of the general formula (I) in which D, L, E, G, J, M, R3, R4, R5, and R13 are defined as in claim 1, their tautomers, their enantiomers, their diastereomers, their mixtures and their salts, more particularly their physiologically tolerated salts with organic or inorganic acids or bases, which exhibit valuable properties.
(ZH) 本发明涉及通式(I)的新的取代的脯氨酰胺，其互变异构体，其对映异构体，其非对映异构体，其混合物和其盐，特别是其与无机或有机酸或碱形成的生理上可接受的盐，其中D、L、E、G、J、M、R3、R4、R5和R13如权利要求1中所定义；所述的化合物具有有价值的特性。